Slow Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.34M Buy
91,223
+14,593
+19% +$770K 0.56% 57
2025
Q4
$4.02M Buy
76,630
+3,343
+5% +$200K 0.48% 62
2025
Q3
$4.75M Sell
73,287
-2,109
-3% -$121K 0.56% 54
2025
Q2
$3.67M Buy
75,396
+10,152
+16% +$393K 0.45% 66
2025
Q1
$2.22M Buy
65,244
+3,669
+6% +$156K 0.3% 84
2024
Q4
$2.42M Sell
61,575
-24,335
-28% -$1.15M 0.34% 84
2024
Q3
$4.04M Buy
85,910
+6,694
+8% +$340K 0.62% 50
2024
Q2
$4.28M Buy
79,216
+11,647
+17% +$674K 0.69% 38
2024
Q1
$4.61M Buy
67,569
+933
+1% +$66.8K 0.74% 34
2023
Q4
$4.17M Buy
66,636
+408
+0.6% +$22.6K 0.73% 34
2023
Q3
$3.01M Buy
66,228
+2,405
+4% +$124K 0.55% 51
2023
Q2
$3.58M Sell
63,823
-2,879
-4% -$163K 0.62% 42
2023
Q1
$3.02M Buy
66,702
+2,225
+3% +$108K 0.56% 57
2022
Q4
$2.62M Buy
64,477
+20,295
+46% +$1.08M 0.58% 57
2022
Q3
$2.89M Sell
44,182
-1,036
-2% -$75.1K 0.62% 37
2022
Q2
$2.75M Buy
45,218
+2,886
+7% +$170K 0.67% 43
2022
Q1
$2.66M Buy
42,332
+12,035
+40% +$756K 0.5% 61
2021
Q4
$2.3M Buy
30,297
+11,629
+62% +$1.02M 0.39% 91
2021
Q3
$2.09M Buy
18,668
+54
+0.3% +$6.78K 0.38% 91
2021
Q2
$3.01M Buy
18,614
+2,227
+14% +$271K 0.57% 61
2021
Q1
$2.37M Buy
16,387
+87
+0.5% +$13.1K 0.51% 73
2020
Q4
$2.5M Buy
16,300
+280
+2% +$33.1K 0.6% 51
2020
Q3
$1.34M Buy
16,020
+2,977
+23% +$264K 0.36% 103
2020
Q2
$959K Buy
13,043
+130
+1% +$7.6K 0.28% 110
2020
Q1
$548K Sell
12,913
-3,611
-22% -$186K 0.21% 119
2019
Q4
$1.01M Buy
16,524
+3,462
+27% +$189K 0.31% 104
2019
Q3
$535K Sell
13,062
-175
-1% -$8.36K 0.19% 125
2019
Q2
$623K Sell
13,237
-248
-2% -$9.91K 0.26% 112
2019
Q1
$482K Buy
+13,485
New +$466K 0.19% 128

Other funds holding CRSP